Physician profile
Imran Farooqi
NPI 1225457336
$14,700.10
in general payments reported to CMS, 2019-2025
11 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.67 · 2021: $5,062 · 2022: $4,180 · 2023: $4,230 · 2024: $557 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,297 · Travel and Lodging: $2,113 · Education: $28.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,297.03 |
| Travel and Lodging | $2,113.17 |
| Education | $28.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,940.48 | 2021-2023 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Abbott Laboratories | $658.87 | 2022-2025 | Proclaim, Octrode, Eterna |
| Imperative Care, INC | $381.13 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom 7x Catheter, Zoom Reperfusion Catheter |
| Nalu Medical, INC. | $241.84 | 2023 | Nalu Neurostimulation System |
| Nevro Corp. | $197.51 | 2024 | Senza |
| Spr Therapeutics, INC | $95.73 | 2024 | Sprint Pns System |
| Hydrocision, INC. | $79.95 | 2023 | Tenjet |
| Collegium Pharmaceutical, INC. | $43.06 | 2021 | |
| Ibsa Pharma INC. | $23.26 | 2023 | Tirosint, Licart |
| Allergan, INC. | $19.67 | 2020 | |
| Abbvie INC. | $18.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Farooqi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.